Recent advances in the prophylaxis and treatment of malaria

被引：12
作者：
Labbé A.-C. [1 ]
Loutfy M.R. [1 ]
Kain K.C. [1 ]
机构：
[1] Department of Medicine, Tropical Disease Unit, University Health Network, University of Toronto, 200 Elizabeth Street, EN G 224, Toronto, M5G 2C4, ON
来源：
Current Infectious Disease Reports | 2001年 / 3卷 / 1期
关键词：
Artesunate; Falciparum Malaria; Malaria; Mefloquine; Vivax Malaria;
D O I：
10.1007/s11908-001-0061-0
中图分类号：
学科分类号：
摘要：
Increases in international travel and escalating drug resistance are putting put a growing number of travelers at risk of contracting malaria. Resistance to chloroquine and proguanil and real and perceived intolerance to standard agents, such as mefloquine, has highlighted the need for new antimalarials to prevent and treat malaria. Promising new agents to prevent malaria include the combination of atovaquone and proguanil, primaquine, and a related 8-aminoquinoline, tafenoquine. These agents are active against the liver stage of the malaria parasite, and therefore can be discontinued shortly after the traveler leaves the malaria-endemic area; this offers a clear advantage, in terms of adherence to a treatment regimen. For treatment of multidrug-resistant Plasmodium falciparum malaria, the combination of artemisinin derivatives plus mefloquine, or atovaquone plus proguanil, are the most active drug regimens. © 2001, Current Science Inc.
引用
收藏
页码：68 / 76
页数：8
相关论文
共 67 条
  • [1] The world health report 1999: Making a difference, (1999)
  • [2] Croft A.M.J., Garner P., Mefloquine for preventing malaria in nonimmune adult travellers [review], The Cochrane Library, (2000)
  • [3] Canadian recommendations for the prevention and treatment of malaria among international travellers, Can Commun Dis Rep, 26, (2000)
  • [4] International Travel and Health. Vaccination requirements and health advice 2000, (2000)
  • [5] Health information for international travel 1999–2000, (1999)
  • [6] Kain K.C., Prophylactic drugs for malaria: why do we need another one, J Travel Med, 6, pp. S2-S7, (1999)
  • [7] Bradley D.J., Warhurst D.C., Guidelines for the prevention of malaria in travellers from the United Kingdom. PHLS Malaria Reference Laboratory, London School of Hygiene and Tropical Medicine, Bur, 7, pp. R137-R152, (1997)
  • [8] Ryan E.T., Kain K.C., Health advice and immunizations for travellers, N Engl J Med, 342, pp. 1716-1725, (2000)
  • [9] Alecrim W.D., Espinosa F.E., Alecrim M.G., Plasmodium falciparum infection in the pregnant patient, Infect Dis Clin North Am, 14, pp. 83-95, (2000)
  • [10] Fischer P.R., Travel with infants and children, Infect Dis Clin North Am, 12, pp. 355-368, (1998)
1234567